Stockreport

Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer

Gain Therapeutics, Inc.  (GANX) 
PDF BETHESDA, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the [Read more]